Global IVF Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 1827

In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm outside the body, in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2–6 days, and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for IVF in US$ by following Product Segments.: Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) and Pre-implantation Genetic Diagnosis (PGD)
Company profiles are primarily based on public domain information including company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience

In 2018, the global IVF market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global IVF status, future forecast, growth opportunity, key market and key players. The study objectives are to present the IVF development in United States, Europe and China.

The key players covered in this study
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience

Market segment by Type, the product can be split into
Intracytoplasmic Sperm Injection (ICSI)
Frozen Embryo Replacement (FER)
Pre-implantation Genetic Diagnosis (PGD)

Market segment by Application, split into
Clone
Transgenic
Embryonic Stem Cell Isolation and Culture
Test Tube Baby

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global IVF status, future forecast, growth opportunity, key market and key players.
To present the IVF development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of IVF are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global IVF Market Size Growth Rate by Type (2014-2025)
1.4.2 Intracytoplasmic Sperm Injection (ICSI)
1.4.3 Frozen Embryo Replacement (FER)
1.4.4 Pre-implantation Genetic Diagnosis (PGD)
1.5 Market by Application
1.5.1 Global IVF Market Share by Application (2014-2025)
1.5.2 Clone
1.5.3 Transgenic
1.5.4 Embryonic Stem Cell Isolation and Culture
1.5.5 Test Tube Baby
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 IVF Market Size
2.2 IVF Growth Trends by Regions
2.2.1 IVF Market Size by Regions (2014-2025)
2.2.2 IVF Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 IVF Market Size by Manufacturers
3.1.1 Global IVF Revenue by Manufacturers (2014-2019)
3.1.2 Global IVF Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global IVF Market Concentration Ratio (CR5 and HHI)
3.2 IVF Key Players Head office and Area Served
3.3 Key Players IVF Product/Solution/Service
3.4 Date of Enter into IVF Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global IVF Market Size by Type (2014-2019)
4.2 Global IVF Market Size by Application (2014-2019)

5 United States
5.1 United States IVF Market Size (2014-2019)
5.2 IVF Key Players in United States
5.3 United States IVF Market Size by Type
5.4 United States IVF Market Size by Application

6 Europe
6.1 Europe IVF Market Size (2014-2019)
6.2 IVF Key Players in Europe
6.3 Europe IVF Market Size by Type
6.4 Europe IVF Market Size by Application

7 China
7.1 China IVF Market Size (2014-2019)
7.2 IVF Key Players in China
7.3 China IVF Market Size by Type
7.4 China IVF Market Size by Application

8 Japan
8.1 Japan IVF Market Size (2014-2019)
8.2 IVF Key Players in Japan
8.3 Japan IVF Market Size by Type
8.4 Japan IVF Market Size by Application

9 Southeast Asia
9.1 Southeast Asia IVF Market Size (2014-2019)
9.2 IVF Key Players in Southeast Asia
9.3 Southeast Asia IVF Market Size by Type
9.4 Southeast Asia IVF Market Size by Application

10 India
10.1 India IVF Market Size (2014-2019)
10.2 IVF Key Players in India
10.3 India IVF Market Size by Type
10.4 India IVF Market Size by Application

11 Central & South America
11.1 Central & South America IVF Market Size (2014-2019)
11.2 IVF Key Players in Central & South America
11.3 Central & South America IVF Market Size by Type
11.4 Central & South America IVF Market Size by Application

12 International Players Profiles
12.1 Vitrolife AB
12.1.1 Vitrolife AB Company Details
12.1.2 Company Description and Business Overview
12.1.3 IVF Introduction
12.1.4 Vitrolife AB Revenue in IVF Business (2014-2019)
12.1.5 Vitrolife AB Recent Development
12.2 EMD Serono Inc
12.2.1 EMD Serono Inc Company Details
12.2.2 Company Description and Business Overview
12.2.3 IVF Introduction
12.2.4 EMD Serono Inc Revenue in IVF Business (2014-2019)
12.2.5 EMD Serono Inc Recent Development
12.3 Irvine scientific
12.3.1 Irvine scientific Company Details
12.3.2 Company Description and Business Overview
12.3.3 IVF Introduction
12.3.4 Irvine scientific Revenue in IVF Business (2014-2019)
12.3.5 Irvine scientific Recent Development
12.4 Cooper Surgical Inc
12.4.1 Cooper Surgical Inc Company Details
12.4.2 Company Description and Business Overview
12.4.3 IVF Introduction
12.4.4 Cooper Surgical Inc Revenue in IVF Business (2014-2019)
12.4.5 Cooper Surgical Inc Recent Development
12.5 Cook Medical Inc
12.5.1 Cook Medical Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 IVF Introduction
12.5.4 Cook Medical Inc Revenue in IVF Business (2014-2019)
12.5.5 Cook Medical Inc Recent Development
12.6 Thermo Fisher Scientific Inc
12.6.1 Thermo Fisher Scientific Inc Company Details
12.6.2 Company Description and Business Overview
12.6.3 IVF Introduction
12.6.4 Thermo Fisher Scientific Inc Revenue in IVF Business (2014-2019)
12.6.5 Thermo Fisher Scientific Inc Recent Development
12.7 Genea Biomedx
12.7.1 Genea Biomedx Company Details
12.7.2 Company Description and Business Overview
12.7.3 IVF Introduction
12.7.4 Genea Biomedx Revenue in IVF Business (2014-2019)
12.7.5 Genea Biomedx Recent Development
12.8 Auxogyn, Inc
12.8.1 Auxogyn, Inc Company Details
12.8.2 Company Description and Business Overview
12.8.3 IVF Introduction
12.8.4 Auxogyn, Inc Revenue in IVF Business (2014-2019)
12.8.5 Auxogyn, Inc Recent Development
12.9 Oxford Gene Technology
12.9.1 Oxford Gene Technology Company Details
12.9.2 Company Description and Business Overview
12.9.3 IVF Introduction
12.9.4 Oxford Gene Technology Revenue in IVF Business (2014-2019)
12.9.5 Oxford Gene Technology Recent Development
12.10 Ovascience
12.10.1 Ovascience Company Details
12.10.2 Company Description and Business Overview
12.10.3 IVF Introduction
12.10.4 Ovascience Revenue in IVF Business (2014-2019)
12.10.5 Ovascience Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details